Type 1 diabetes is an autoimmune condition in which your immune system destroys the cells in your pancreas that produce insulin. Without insulin, your body can’t move sugar from your blood into your cells for energy, so blood sugar rises to dangerous levels. Unlike type 2 diabetes, which involves insulin resistance, type 1 results from a near-total loss of insulin production. An estimated 9.5 million people worldwide are living with it, and roughly 513,000 new cases are diagnosed each year.
What Happens in Your Body
Your pancreas contains clusters of cells called islets, and within those islets are beta cells, which are the only cells in your body that make insulin. In type 1 diabetes, your immune system mistakenly identifies these beta cells as threats and attacks them. This destruction can begin months or even years before any symptoms appear. By the time you notice something is wrong, roughly 80 to 90 percent of your beta cells have already been destroyed.
Without enough insulin, glucose from the food you eat stays trapped in your bloodstream instead of entering your muscles, organs, and brain. Your body begins breaking down fat and muscle for energy instead, which produces acidic byproducts called ketones. This is why people with untreated type 1 diabetes lose weight even when they’re eating normally or more than usual.
Who Gets It and When
Type 1 diabetes can develop at any age, though it’s most commonly diagnosed in children, teenagers, and young adults. Of the 9.5 million people living with the condition globally, about 1.85 million are under 20. Incidence is rising, increasing by about 2.4 percent in the past year alone. The exact trigger remains unclear, but genetics play a role: certain gene combinations make people more susceptible, and environmental factors like viral infections appear to set the autoimmune process in motion.
Recognizing the Symptoms
The onset of symptoms is often sudden and hard to miss. The three hallmark signs are excessive urination, extreme thirst, and increased hunger. Each has a distinct physiological cause. When blood sugar is very high, your kidneys try to flush the excess glucose out through urine, which pulls water along with it. That fluid loss triggers intense thirst. And because your cells are starved of glucose despite there being plenty in your blood, your brain signals hunger.
Other common early symptoms include:
- Unexplained weight loss, often rapid, as the body breaks down fat and muscle for fuel
- Fatigue, because cells aren’t getting the energy they need
- Blurred vision, caused by fluid shifts in the lens of the eye
- Fruity-smelling breath, a sign that ketones are building up
In some cases, the first sign of type 1 diabetes is a medical emergency called diabetic ketoacidosis, or DKA. This happens when ketone levels become so high that the blood turns acidic. DKA causes nausea, vomiting, abdominal pain, confusion, and, if untreated, loss of consciousness. It requires immediate hospital treatment.
How It’s Diagnosed
A diabetes diagnosis is confirmed through blood tests. Diabetes is diagnosed when fasting blood glucose is 126 mg/dL or higher, a random blood glucose reading is 200 mg/dL or higher, or an A1C (a measure of average blood sugar over three months) is 6.5 percent or above. These thresholds apply to both type 1 and type 2.
What separates type 1 from type 2 is a test for autoantibodies, proteins that signal the immune system is attacking the pancreas. Doctors look for antibodies targeting specific components of the beta cells, including GAD65, IA-2, ZnT8, and insulin itself. The presence of multiple autoantibodies strongly points to type 1 and also helps predict how quickly the disease will progress. When three or more of these autoantibodies are present, the five-year risk of developing full type 1 diabetes is as high as 70 percent, compared to just over 2 percent with a single antibody.
Daily Management With Insulin
People with type 1 diabetes need external insulin every day for the rest of their lives. There’s no pill or lifestyle change that can replace it. The two main approaches are multiple daily injections and an insulin pump. With injections, you typically take a long-acting insulin once or twice a day for baseline coverage, plus a fast-acting dose before each meal. An insulin pump delivers a continuous low dose through a small tube under the skin, with extra doses at mealtimes that you program in.
The goal is to keep blood sugar in a target range, generally between 70 and 180 mg/dL for most of the day. Continuous glucose monitors have transformed how people track this. A small sensor placed just under the skin reads glucose levels every few minutes and sends the data to your phone or a receiver. Newer systems pair a glucose monitor with an insulin pump and automatically adjust insulin delivery, sometimes called a “closed loop” or “artificial pancreas” system.
Managing type 1 isn’t just about insulin. You need to account for carbohydrate intake, physical activity, stress, illness, and sleep, all of which affect blood sugar. It’s a constant balancing act, and even with careful management, blood sugar will sometimes go too high or too low.
Low Blood Sugar: The Most Immediate Risk
Hypoglycemia, or low blood sugar, is the most common acute complication of insulin therapy. It happens when there’s too much insulin relative to the amount of glucose in your blood, often from miscounting carbohydrates, skipping a meal, or exercising more than expected.
Low blood sugar is classified in three levels. Level 1 is a glucose reading below 70 mg/dL but at or above 54 mg/dL. You’ll typically feel shaky, sweaty, or lightheaded, and you can treat it by eating fast-acting carbohydrates like juice or glucose tablets. Level 2 is below 54 mg/dL and requires more urgent treatment, as cognitive function starts to decline. Level 3 is a severe episode where you need someone else’s help because you’re confused, unable to function, or unconscious. Repeated severe lows are one of the most feared aspects of living with type 1 diabetes.
Long-Term Complications
Over years and decades, elevated blood sugar damages small blood vessels throughout the body. The eyes and kidneys are especially vulnerable. Up to 50 percent of people with type 1 diabetes develop some degree of retinopathy (damage to the blood vessels in the retina) after 15 or more years with the disease. This is a leading cause of vision loss. Kidney disease, or nephropathy, affects 10 to 20 percent of people with type 1 diabetes over their lifetime and is the primary driver of excess mortality in this population.
Nerve damage is another common long-term complication, particularly in the feet and hands, causing numbness, tingling, or pain. Cardiovascular disease risk is also elevated. The single most effective way to reduce the risk of all these complications is keeping blood sugar as close to the target range as possible, which is why consistent monitoring and insulin management matter so much.
How Type 1 Differs From Type 2
The two conditions share a name and some symptoms, but they’re fundamentally different diseases. Type 1 is autoimmune: the body destroys its own insulin-producing cells, and there’s no way to prevent it. Type 2 involves insulin resistance, where the body still makes insulin but can’t use it efficiently. Type 2 is strongly linked to weight, age, and lifestyle factors, while type 1 is not. You cannot cause type 1 diabetes through diet or inactivity, and you cannot manage it with oral medications alone. People with type 1 always require insulin.
Type 1 accounts for roughly 5 to 10 percent of all diabetes cases, but it carries a disproportionate burden of daily management and acute risk. A person with type 2 who misses a dose of medication may see their blood sugar drift upward. A person with type 1 who goes without insulin can develop life-threatening DKA within hours.
Islet Cell Transplantation
For people with especially difficult-to-manage type 1 diabetes, islet cell transplantation offers a potential path to reducing or eliminating the need for insulin injections. The procedure involves transplanting healthy insulin-producing cells from a donor pancreas into the patient’s liver, where the cells begin sensing blood sugar and releasing insulin on their own. With the most effective treatment protocols, about 50 percent of recipients remain insulin-independent at the five-year mark. The trade-off is that transplant recipients must take immunosuppressive medications indefinitely to prevent rejection, which carry their own risks. It’s currently reserved for people who experience severe, recurrent hypoglycemia that can’t be controlled by other means.